✦ LIBER ✦

Phase I study of PKC412, a protein kinase C inhibitor, in combination with gemcitabine and cisplatin: Preliminary report of an ongoing phase I study

✍ Scribed by Monnerat, C; Henriksson, R; Raymond, E; Berthaud, P; Vicente-Azevedo, J; Lavenius, E; Dutreix, C; Barbier, N; Csermak, K; Le Chevalier, T

Book ID: 118569807
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 106 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80262-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with gemcitabin

Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: Preliminary results of an ongoing phase I/II study

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 281 KB

A phase I trial of PKC412, an inhibitor

A phase I trial of PKC412, an inhibitor of protein kinase C, in combination with bolus 5-Fluorouracil and leucovorin in patients with stage IV colorectal cancer

✍ K. Weigang-Köhler; H. Bouterfa; U. Bruntsch; J. Buekki; C. Dutreix; G. Greim; M. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Phase I/II dose finding study of combina

Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer

✍ U.A. Matulonis; S. Campos; L. Duska; C.N. Krasner; T. Atkinson; R.T. Penson; M.V 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

A phase I schedule dependency study of t

A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors

✍ Raymond, E.; Alexandre, J.; Faivre, S.; Goldwasser, F.; Besse-Hammer, T.; Gianel 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 270 KB

A phase 1b study of trametinib, an oral

A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours

✍ Infante, Jeffrey R.; Papadopoulos, Kyriakos P.; Bendell, Johanna C.; Patnaik, Am 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 448 KB

Preliminary results of an ongoing phase

Preliminary results of an ongoing phase I and pharmacokinetic study of CYC202, a novel oral cyclin-dependent kinases inhibitor, in patients with advanced malignancies

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 140 KB